Human papillomavirus vaccine effectiveness and herd protection in young women
C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - publications.aap.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
Prevalence of oral HPV infection in unvaccinated men and women in the United States, 2009-2016
AK Chaturvedi, BI Graubard, T Broutian, W Xiao… - Jama, 2019 - jamanetwork.com
Methods| This study was conducted across 4 cycles of the National Health and Nutrition
Examination Survey (NHANES), a cross-sectional, stratified, multistage probability sample of …
Examination Survey (NHANES), a cross-sectional, stratified, multistage probability sample of …
[HTML][HTML] The prevalence of HPV genotypes in Iranian population: an update
Methods: Samples were collected from the penile and anal sites of male subjects and the
vagina and cervix of female subjects in a time period between 2011 and 2016. HPV DNA …
vagina and cervix of female subjects in a time period between 2011 and 2016. HPV DNA …
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
M Gao, S Hu, X Zhao, T You, M Jit, Y Liu… - The Lancet Regional …, 2023 - thelancet.com
Background Current uptake of HPV vaccination and screening in China is far below World
Health Organization 2030 targets for cervical cancer elimination. We quantified health and …
Health Organization 2030 targets for cervical cancer elimination. We quantified health and …
A review of ethical and legal aspects of gender-neutral human papillomavirus vaccination
While launching a campaign to eliminate cervical cancer, the World Health Organization
called to halt human papillomavirus (HPV) gender-neutral vaccination (GNV) because of …
called to halt human papillomavirus (HPV) gender-neutral vaccination (GNV) because of …
Vaccination of young women decreases human papillomavirus transmission in heterosexual couples: findings from the HITCH cohort study
MD Wissing, AN Burchell, M El-Zein, PP Tellier… - … Biomarkers & Prevention, 2019 - AACR
Background: Vaccination against human papillomaviruses (HPV) prevents HPV infections
and, consequently, cervical lesions. However, the effect of vaccination on HPV transmission …
and, consequently, cervical lesions. However, the effect of vaccination on HPV transmission …
[HTML][HTML] No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors
PJ Woestenberg, AJ King, MAB van der Sande… - Journal of Infection, 2017 - Elsevier
Objectives Data from a vaccine trial and from post-vaccine surveillance in the United
Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection …
Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection …
Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol
V López-Codony, Á de Andrés-Pablo, A Ferrando-Díez… - Plos one, 2024 - journals.plos.org
Human Papillomavirus (HPV) prophylactic vaccination has proven effective in preventing
new infections, but it does not treat existing HPV infections or associated diseases. Hence …
new infections, but it does not treat existing HPV infections or associated diseases. Hence …
Parental Justifications for Not Vaccinating Children or Adolescents against Human Papillomavirus (HPV)
ES Rodrigues, EDT Mendes, LB Nucci - Vaccines, 2023 - mdpi.com
Vaccination coverage against Human Papillomavirus (HPV) is low compared with uptake of
other vaccines in many countries, including Brazil. The aim of this study was to examine the …
other vaccines in many countries, including Brazil. The aim of this study was to examine the …
Risk factors for non–human papillomavirus (HPV) type 16/18 cervical infections and associated lesions among HPV DNA–negative women vaccinated against HPV …
MS Sierra, SH Tsang, S Hu, C Porras… - The Journal of …, 2021 - academic.oup.com
Background Factors that lead human papillomavirus (HPV) infections to persist and
progress to cancer are not fully understood. We evaluated co-factors for acquisition …
progress to cancer are not fully understood. We evaluated co-factors for acquisition …